Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerry Coghlan

Showing results (61-70 of 103) with videos related to

Pageof 11
Sort By:
ERJ Open Research|January 23, 2023
Early selexipag initiation and long-term outcomes: insights from randomised controlled trials in pulmonary arterial hypertensionJ Gerry Coghlan, Sean Gaine, Richard Channick, et al.
Annals of the Rheumatic Diseases|October 25, 2017
Factors associated with disease progression in early-diagnosed pulmonary arterial hypertension associated with systemic sclerosis: longitudinal data from the DETECT cohortCarina Mihai, Milos Antic, Rucsandra Dobrota, et al.
Arthritis Research & Therapy|December 11, 2014
Borderline pulmonary arterial pressure in systemic sclerosis patients: a post-hoc analysis of the DETECT studyScott H Visovatti, Oliver Distler, J Gerry Coghlan, et al.
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|March 21, 2026
Sotatercept improves right ventricular function but is associated with new or worsening pericardial effusions: a CMR study in intermediate-high risk PAHRuta Virsinskaite, Catherine J Beattie, Nina Karia, et al.
European Heart Journal|July 20, 2023
Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension: a clinical consensus statement of the ESC working group on pulmonary circulation and right ventricular functionIrene M Lang, Arne K Andreassen, Asger Andersen, et al.
Journal of Thrombosis and Haemostasis : JTH|September 27, 2019
A multicenter study of anticoagulation in operable chronic thromboembolic pulmonary hypertensionKatherine Bunclark, Michael Newnham, Yi-Da Chiu, et al.
Journal of the American College of Cardiology|July 23, 2016
Pre-Capillary, Combined, and Post-Capillary Pulmonary Hypertension: A Pathophysiological ContinuumChristian F Opitz, Marius M Hoeper, J Simon R Gibbs, et al.
Annals of the Rheumatic Diseases|January 1, 2017
Initial combination therapy with ambrisentan and tadalafil in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH): subgroup analysis from the AMBITION trialJohn Gerry Coghlan, Nazzareno Galiè, Joan Albert Barberà, et al.
Echo Research and Practice|July 18, 2018
Echocardiographic assessment of pulmonary hypertension: a guideline protocol from the British Society of EchocardiographyDaniel X Augustine, Lindsay D Coates-Bradshaw, James Willis, et al.
Chest|November 19, 2019
Results of an Expert Consensus Survey on the Treatment of Pulmonary Arterial Hypertension With Oral Prostacyclin Pathway AgentsVallerie V McLaughlin, Richard Channick, Teresa De Marco, et al.
Pageof 11

Showing results (61-70 of 103) with videos related to

Sort By:
Pageof 11
ERJ Open Research|January 23, 2023
Early selexipag initiation and long-term outcomes: insights from randomised controlled trials in pulmonary arterial hypertensionJ Gerry Coghlan, Sean Gaine, Richard Channick, et al.
Annals of the Rheumatic Diseases|October 25, 2017
Factors associated with disease progression in early-diagnosed pulmonary arterial hypertension associated with systemic sclerosis: longitudinal data from the DETECT cohortCarina Mihai, Milos Antic, Rucsandra Dobrota, et al.
Arthritis Research & Therapy|December 11, 2014
Borderline pulmonary arterial pressure in systemic sclerosis patients: a post-hoc analysis of the DETECT studyScott H Visovatti, Oliver Distler, J Gerry Coghlan, et al.
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|March 21, 2026
Sotatercept improves right ventricular function but is associated with new or worsening pericardial effusions: a CMR study in intermediate-high risk PAHRuta Virsinskaite, Catherine J Beattie, Nina Karia, et al.
European Heart Journal|July 20, 2023
Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension: a clinical consensus statement of the ESC working group on pulmonary circulation and right ventricular functionIrene M Lang, Arne K Andreassen, Asger Andersen, et al.
Journal of Thrombosis and Haemostasis : JTH|September 27, 2019
A multicenter study of anticoagulation in operable chronic thromboembolic pulmonary hypertensionKatherine Bunclark, Michael Newnham, Yi-Da Chiu, et al.
Journal of the American College of Cardiology|July 23, 2016
Pre-Capillary, Combined, and Post-Capillary Pulmonary Hypertension: A Pathophysiological ContinuumChristian F Opitz, Marius M Hoeper, J Simon R Gibbs, et al.
Annals of the Rheumatic Diseases|January 1, 2017
Initial combination therapy with ambrisentan and tadalafil in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH): subgroup analysis from the AMBITION trialJohn Gerry Coghlan, Nazzareno Galiè, Joan Albert Barberà, et al.
Echo Research and Practice|July 18, 2018
Echocardiographic assessment of pulmonary hypertension: a guideline protocol from the British Society of EchocardiographyDaniel X Augustine, Lindsay D Coates-Bradshaw, James Willis, et al.
Chest|November 19, 2019
Results of an Expert Consensus Survey on the Treatment of Pulmonary Arterial Hypertension With Oral Prostacyclin Pathway AgentsVallerie V McLaughlin, Richard Channick, Teresa De Marco, et al.
Pageof 11